Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Miralbell

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Journal of Radiosurgery and SBRT|January 4, 2018
Stereotactic body radiotherapy for prostate cancer: treatment approaches and clinical outcomesRaymond Miralbell
Swiss Medical Weekly|April 22, 2010
Incidental detection of synchronous primary tumours during staging workup for prostate cancerOrhan Ozsoy, Gérald Fioretta, Carmen Ares, et al.
Cancer Treatment Reviews|November 28, 2017
Hypofractionated radiotherapy for prostate cancer in the postoperative setting: What is the evidence so far?Cristina Picardi, Ioan Perret, Raymond Miralbell, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2002
Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumorsRaymond Miralbell, Antony Lomax, Laura Cella, et al.
Bulletin Du Cancer|September 20, 2007
[Proton beam therapy: clinical indications and summary of the Swiss experience]Damien Charles Weber, René-Olivier Mirimanoff, Raymond Miralbell
Cancer Treatment Reviews|April 16, 2016
Prognostic value of biochemical response to neoadjuvant androgen deprivation before external beam radiotherapy for prostate cancer: A systematic review of the literatureThomas Zilli, Alan Dal Pra, Melpomeni Kountouri, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 16, 2013
Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapyElena Lecumberri, Yves Marc Dupertuis, Raymond Miralbell, et al.
Advances in Radiation Oncology|October 30, 2018
Salvage reirradiation for local failure of prostate cancer after curative radiation therapy: Association of rectal toxicity with dose distribution and normal-tissue complication probability modelsGiovanna Dipasquale, Thomas Zilli, Claudio Fiorino, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2011
Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) GyRaymond Miralbell, Stephen A Roberts, Eduardo Zubizarreta, et al.
Physics in Medicine and Biology|August 16, 2016
Atlas-guided generation of pseudo-CT images for MRI-only and hybrid PET-MRI-guided radiotherapy treatment planningHossein Arabi, Nikolaos Koutsouvelis, Michel Rouzaud, et al.
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Journal of Radiosurgery and SBRT|January 4, 2018
Stereotactic body radiotherapy for prostate cancer: treatment approaches and clinical outcomesRaymond Miralbell
Swiss Medical Weekly|April 22, 2010
Incidental detection of synchronous primary tumours during staging workup for prostate cancerOrhan Ozsoy, Gérald Fioretta, Carmen Ares, et al.
Cancer Treatment Reviews|November 28, 2017
Hypofractionated radiotherapy for prostate cancer in the postoperative setting: What is the evidence so far?Cristina Picardi, Ioan Perret, Raymond Miralbell, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2002
Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumorsRaymond Miralbell, Antony Lomax, Laura Cella, et al.
Bulletin Du Cancer|September 20, 2007
[Proton beam therapy: clinical indications and summary of the Swiss experience]Damien Charles Weber, René-Olivier Mirimanoff, Raymond Miralbell
Cancer Treatment Reviews|April 16, 2016
Prognostic value of biochemical response to neoadjuvant androgen deprivation before external beam radiotherapy for prostate cancer: A systematic review of the literatureThomas Zilli, Alan Dal Pra, Melpomeni Kountouri, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 16, 2013
Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapyElena Lecumberri, Yves Marc Dupertuis, Raymond Miralbell, et al.
Advances in Radiation Oncology|October 30, 2018
Salvage reirradiation for local failure of prostate cancer after curative radiation therapy: Association of rectal toxicity with dose distribution and normal-tissue complication probability modelsGiovanna Dipasquale, Thomas Zilli, Claudio Fiorino, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2011
Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) GyRaymond Miralbell, Stephen A Roberts, Eduardo Zubizarreta, et al.
Physics in Medicine and Biology|August 16, 2016
Atlas-guided generation of pseudo-CT images for MRI-only and hybrid PET-MRI-guided radiotherapy treatment planningHossein Arabi, Nikolaos Koutsouvelis, Michel Rouzaud, et al.
Pageof 13